Martin Reck, MD, PhD

Articles by Martin Reck, MD, PhD

Dr. Reck Shares Insights From Novel Immunotherapies Session at ELCC 2025

Martin Reck, MD, PhDELCC 2025 | April 12, 2025

The session covered everything from new actionable immune checkpoints to vaccines, cellular therapies, and bispecifics.

Martin Reck, MD, PhD, on KEYNOTE-799, LAURA, and the Future of Treatment for Stage III NSCLC

Martin Reck, MD, PhDELCC 2025 | April 9, 2025

Martin Reck, MD, PhD, reflects on key updates in stage III NSCLC from the European Lung Cancer Congress 2025.

Dr. Martin Reck Discusses Lung Cancer Highlights at Upcoming ESMO Congress

Martin Reck, MD, PhDESMO 2024 | February 28, 2025

Martin Reck, MD, PhD, shares his insights on key data in lung cancer to be presented at the ESMO Congress 2024.

‘Extraordinary’ Results in SCLC: Dr. Reck Discusses 5-Year OS Data From IMpower133, IMbrella A

Martin Reck, MD, PhDSmall Cell Lung Cancer | February 28, 2025

Dr. Reck discusses why the research represents important progress in treating patients with extensive-stage SCLC.